Project Grant R01AG085404
Award Date
12/15/24
Completion Date
11/30/29
Dollars Obligated
$442K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10031, USA
Similar Awards
This Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) provides $871,419 to the University of Washington to conduct research on the role of microglia, the brain's immune cells, in the pathogenesis of Alzheimer's disease. The research aims to characterize molecular profiles and spatial organization of microglia across the adult age spectrum, both with and without Alzheimer's disease, through single-nucleus RNA sequencing of over 5,000...
This $745,765 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York aims to investigate the effects of Alzheimer's disease (AD) risk genes and aging on human microglia activity and lipid metabolism. The key focus is on understanding how genetic variants associated with increased AD risk or longevity may impact microglia's ability to clear cholesterol/lipid-rich cellular debris, a...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) provides $660,402 to the University of Maryland, Baltimore (UMB) to study the role of autophagy, a cellular process that recycles damaged components, in regulating lipid metabolism and inflammation in microglia during brain aging and neurodegenerative diseases like Alzheimer's disease (AD). The research aims to determine how microglial lipid phagocytosis inhibits autophagy, leading to...
This federal Project Grant award of $427,625, granted by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), aims to elucidate the mechanisms by which microgliopathy (a disease affecting microglia) causes early-onset dementia. The primary focus is on investigating the impact of DAP12 deficiency on the expression of RUNX1/2 and STAT3 signaling pathways in human iPSC-derived microglia (iMGLs), and evaluating how altered microglial expression of these factors...
This federal Project Grant award, provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), aims to enhance the understanding of biological signatures that distinguish subgroups of patients with Alzheimer's disease (AD). The $107,948 award to The Research Foundation for the State University of New York (SUNY) will use state-of-the-art machine learning algorithms to predict AD molecular subtypes from magnetic resonance imaging (MRI) data. The project...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $254,250 to New York University School of Medicine to conduct a multiscale modeling study of brain aging and Alzheimer's disease (AD). The key objectives are to:
Develop a biologically relevant multi-scale model of brain aging using advanced diffusion MRI techniques to examine the roles of neuroinflammation and neurodegeneration. This will involve creating a large dataset by unifying...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $783,003 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to investigate the role of oxidative stress and microglial dysfunction in Alzheimer's disease. The research aims to elucidate the molecular mechanisms by which oxidation disrupts microglial phagocytosis, leading to detrimental consequences in Alzheimer's. The project will develop new interventions...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $4,151,128 to The Winifred Masterson Burke Medical Research Institute, Inc. to investigate the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the pathogenesis of Alzheimer's disease. The 5-year project, which began on September 1, 2024, aims to elucidate how modifications in brain activity, particularly in the locus coeruleus and hippocampus, can lead to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate early microglial dysfunction in Alzheimer's disease (AD) using novel explainable AI techniques and iPSC models. The $191,891 award, active from September 2024 to May 2026, will enable researchers at the University of Washington to better define regulation of microglia in aging and disease by integrating explainable AI with deep learning methods. This approach is intended to uncover...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) for $145,642 will support research to study the role of the Nemo-like kinase (NLK) protein in regulating microglial function and heterogeneity in Alzheimer's disease (AD). The project aims to determine if depletion of NLK in microglia can increase phagocytic degradation of amyloid-beta, improve AD phenotypes, and induce the transition of microglia from a homeostatic to disease-associated state in a...